Aravive, Inc.
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets…
Biotechnology
US, Houston [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Aravive, Inc. has no acquisition track records yet.
M&A Deals · History
Aravive, Inc. has no acquisition track records yet.